PAR-24-022 - Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications NOT-EB-23-022 NIBIB, NCATS, NCI, NEI, NHLBI, NIGMS Dec 13, 2023 Sep 9, 2025 R35, RM1, R21, R01, U01, R15, R13, K99/R00
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. NOT-EB-23-002 NIBIB, NCCIH, NCI, NHLBI, NIA, NIAID, NICHD, NIGMS Apr 14, 2023 Sep 9, 2025 R01, R21, R35, R41/R42, R43/R44
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging NOT-EB-22-006 NIBIB Mar 21, 2022 May 8, 2024 R21, F30, K01, R13, K23, K25, R43/R44, K08, R01, K99/R00, R41/R42, F32, R03, F31
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition NOT-HD-21-027 NICHD, NIAAA, NCI, NIMH, NIAMS, OBSSR, NIBIB, NIDCR Jun 22, 2021 Jan 8, 2024 R01, R21, R43/R44, R41/R42
For technical issues E-mail OER Webmaster